Workflow
aTyr Pharma Presents Preclinical Data for NRP2-Targeting Antibody ATYR2810 at the American Association for Cancer Research (AACR) Annual Meeting 2025
NRPNPR(NRP) GlobeNewswire News Room·2025-04-29 20:00

Title: Immunosuppressive myeloid cells can be modulated with NRP2-targeting antibody ATYR2810 leading to enhanced anti-tumor immunity Authors: Christoph Burkart, Clara Polizzi, John Choi, Max Pastenes, Alison Barber, Michael Lim, Leslie Nangle. aTyr Pharma, San Diego. Department of Neurosurgery, Stanford School of Medicine, Stanford. Session: Antibodies and Antibody-Drug Conjugates Poster Number: 27 Date and Time: Tuesday, April 29, 2025 from 9:00AM – 12:00PM CT Location: Poster Board Section 36, McCormick ...